Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
Semaglutide (Wegovy and Ozempic): Originally developed for type 2 diabetes, this medication mimics the GLP-1 hormone, ...
12hon MSN
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...
Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...
15h
MarketBeat on MSNHims & Hers: From Viral Ad to Volatile StockHims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time ...
The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results